A New Framework For Safe, Patient-centered Prescribing Of Obesity Medications In Older Adults
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

The American Geriatrics Society has published a case-based framework for clinicians prescribing obesity medications, including incretin therapies, to older adults. It calls for assessing function, nutrition and cognition before treatment and pairing medication with measures such as resistance training and adequate protein intake.

The American Geriatrics Society (AGS) has released a framework to help clinicians prescribe obesity medications to older adults while accounting for age-related health needs. Published in the Journal of the American Geriatrics Society, the case-based paper applies the AGS Geriatrics 5Ms Framework to incretin therapies, including GLP-1 medications, and calls for assessment of function, nutrition and cognition before treatment.

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

The paper, developed by the AGS Healthy Aging Special Interest Group and led by Elias M. Wisdom and colleagues, uses clinical cases to discuss how clinicians can weigh obesity medication use in later life. It addresses drugs that act through gut-derived hormonal pathways, a category that includes GLP-1 medications. The authors describe potential benefits for weight management, blood sugar control and other health conditions, while noting that older adults have been underrepresented in clinical trials.

The framework uses the Geriatrics 5Ms: Mind, Mobility, Medications, Multicomplexity and Matters Most. It encourages clinicians to review an older patient’s functional status, nutritional adequacy and cognitive impairment before starting therapy, rather than making a prescribing decision based on weight or a diagnosis alone.

The authors also recommend pairing medication with resistance training and adequate dietary protein. Depending on a person’s needs, care may involve a registered dietitian, physical therapist, fitness trainer or behavioral health professional. The paper highlights concerns including frailty, sarcopenia, loss of lean muscle, malnutrition and dehydration.

At a glance
reportWhen: Published October 2026
The developmentThe American Geriatrics Society published a practical framework for safer, patient-centered prescribing of obesity medications in older adults.

Balancing Weight Treatment With Healthy Aging

The framework addresses a prescribing challenge: an approach that supports weight loss and metabolic health may also require attention to muscle strength, mobility and nutrition in older patients. The authors’ emphasis on functional and nutritional assessments makes those factors part of treatment planning, not just follow-up considerations.

That focus matters because older adults are underrepresented in clinical trials, according to the paper. The framework offers clinicians a structured way to consider individual priorities and age-related risks where evidence from trials may not fully reflect the people being treated. It does not establish that every older adult should take these medications or that the recommended accompanying measures prevent specific harms.

The approach also points toward care tailored to the person. A team-based plan may be appropriate for some patients, but the paper describes that as a consideration rather than a requirement for everyone. Decisions still depend on a patient’s health, goals and clinical assessment.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

The Geriatrics 5Ms in Prescribing

The AGS 5Ms framework organizes older-adult care around Mind, Mobility, Medications, Multicomplexity and Matters Most. In this paper, the authors apply those categories to incretin therapy, linking medication decisions with cognitive status, movement and function, other health conditions and the patient’s own priorities.

The development comes amid growing clinical interest in obesity medications and GLP-1 therapies. The AGS paper is a practical framework presented through cases, not a report of a new clinical trial. Its publication details are: “Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient-Centered Prescribing,” by Elias M. Wisdom and colleagues, in the Journal of the American Geriatrics Society (2026), DOI: 10.1111/jgs.70769.

“The paper explores how to apply the Geriatrics 5Ms Framework—Mind, Mobility, Medications, Multicomplexity, and Matters Most—to incretin therapy in older adults.”

— Elias M. Wisdom and colleagues, authors of the AGS framework

Evidence Gaps and Individual Risks

The report does not provide results from a new trial, quantify medication benefits or harms specifically for older adults, or compare particular drugs. It also does not set out detailed eligibility rules, dosing guidance or a standardized monitoring schedule. The framework’s recommendations are presented as clinical considerations, not as proof that treatment will produce a particular outcome.

Because older adults have been underrepresented in trials, the extent to which study findings apply across patients with different levels of frailty, cognitive impairment or nutritional risk remains uncertain from the information provided. The source does not specify how often these patients experience muscle loss, dehydration or malnutrition while taking the medications.

Applying the Framework in Clinical Care

The paper is now available in the Journal of the American Geriatrics Society for clinicians to use as a case-based guide. In practice, its approach calls for discussing a patient’s goals and reviewing function, nutrition, cognition and other medications before making a treatment plan, then considering supportive measures such as resistance exercise and adequate protein intake.

The report does not announce a rollout, formal implementation program or future study. Further research that includes more older adults could help clarify benefits and risks across different health and functional profiles; no specific follow-up study or timeline is identified in the source.

Key Questions

What did the American Geriatrics Society publish?

The AGS published a case-based framework for clinicians considering obesity medications in older adults. It applies the Geriatrics 5Ms to prescribing incretin therapies, including GLP-1 medications.

What should clinicians assess before treatment?

The paper calls for pretreatment assessment of functional status, nutritional adequacy and cognitive impairment, alongside consideration of a patient’s broader health needs and priorities.

What concerns does the framework highlight?

It identifies age-related concerns including frailty, sarcopenia, lean muscle loss, malnutrition and dehydration. The source does not quantify how often these occur with treatment in older adults.

Does the framework recommend support alongside medication?

Yes. The authors recommend considering resistance training and adequate dietary protein. They say a team that may include nutrition, physical therapy, fitness or behavioral health professionals could be appropriate for some older adults.

Does this paper prove obesity drugs are safe for all older adults?

No. It is a prescribing framework, not a clinical trial proving safety or effectiveness for every older patient. The authors note that older adults are underrepresented in trials, and treatment decisions require individual clinical assessment.

Source: medicalxpress.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

New NHS-ready Medication Risk Tool Could Cut Falls And Delirium In Older People

The Anticholinergic Medication Index is live in two NHS trusts and is being tested to help clinicians identify older patients for medication review.

Why a One-Page Medication Summary Can Save Time and Stress

What makes a one-page medication summary essential for saving time and reducing stress? Discover how it can transform your healthcare routine.

Why Timed Medication Systems Matter in Busy Homes

Hoping to stay organized amidst chaos, timed medication systems ensure you never miss a dose, with benefits that could transform your household routines.

10 Medicare Part D Changes You Should Know (Part 2)

A Seniors Guide report outlines five Part D issues, including expiring premium subsidies, fewer stand-alone plans and the late-enrollment penalty.